DAVIDE CAMPARI-MILANO NV (CPR.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:CPR - NL0015435975 - Common Stock
5.982 EUR
+0.1 (+1.63%)
We assign a fundamental rating of 4 out of 10 to CPR. CPR was compared to 29 industry peers in the Beverages industry. CPR has an average financial health and profitability rating. CPR is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
CPR had positive earnings in the past year.
CPR had a positive operating cash flow in the past year.
CPR had positive earnings in each of the past 5 years.
Each year in the past 5 years CPR had a positive operating cash flow.
1.2 Ratios
The Return On Assets of CPR (2.51%) is worse than 65.52% of its industry peers.
With a Return On Equity value of 5.44%, CPR is not doing good in the industry: 72.41% of the companies in the same industry are doing better.
CPR has a Return On Invested Capital (7.03%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for CPR is in line with the industry average of 7.74%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.51% | ||
| ROE | 5.44% | ||
| ROIC | 7.03% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
1.3 Margins
CPR has a Profit Margin of 6.57%. This is comparable to the rest of the industry: CPR outperforms 41.38% of its industry peers.
CPR's Profit Margin has declined in the last couple of years.
CPR has a better Operating Margin (21.32%) than 62.07% of its industry peers.
CPR's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 57.55%, CPR is in the better half of the industry, outperforming 72.41% of the companies in the same industry.
CPR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% |
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
CPR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CPR has more shares outstanding than it did 1 year ago.
CPR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CPR has about the same debt to assets ratio.
2.2 Solvency
CPR has an Altman-Z score of 2.58. This is not the best score and indicates that CPR is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.58, CPR is doing good in the industry, outperforming 75.86% of the companies in the same industry.
The Debt to FCF ratio of CPR is 8.49, which is on the high side as it means it would take CPR, 8.49 years of fcf income to pay off all of its debts.
CPR has a Debt to FCF ratio (8.49) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.64 indicates that CPR is somewhat dependend on debt financing.
CPR has a better Debt to Equity ratio (0.64) than 65.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 8.49 | ||
| Altman-Z | 2.58 |
ROIC/WACC1.05
WACC6.69%
2.3 Liquidity
A Current Ratio of 2.32 indicates that CPR has no problem at all paying its short term obligations.
CPR's Current ratio of 2.32 is amongst the best of the industry. CPR outperforms 86.21% of its industry peers.
A Quick Ratio of 0.91 indicates that CPR may have some problems paying its short term obligations.
CPR has a Quick ratio of 0.91. This is in the better half of the industry: CPR outperforms 79.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
The earnings per share for CPR have decreased strongly by -40.50% in the last year.
Measured over the past years, CPR shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.12% on average per year.
The Revenue has been growing slightly by 5.18% in the past year.
CPR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.75% yearly.
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-8.36%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%0.3%
3.2 Future
Based on estimates for the next years, CPR will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.74% on average per year.
Based on estimates for the next years, CPR will show a small growth in Revenue. The Revenue will grow by 4.51% on average per year.
EPS Next Y2.03%
EPS Next 2Y4.61%
EPS Next 3Y7.09%
EPS Next 5Y11.74%
Revenue Next Year1.47%
Revenue Next 2Y1.85%
Revenue Next 3Y2.98%
Revenue Next 5Y4.51%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 35.19, the valuation of CPR can be described as expensive.
Based on the Price/Earnings ratio, CPR is valued a bit more expensive than 79.31% of the companies in the same industry.
CPR's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.54.
The Price/Forward Earnings ratio is 18.41, which indicates a rather expensive current valuation of CPR.
62.07% of the companies in the same industry are cheaper than CPR, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.78. CPR is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.19 | ||
| Fwd PE | 18.41 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CPR indicates a slightly more expensive valuation: CPR is more expensive than 62.07% of the companies listed in the same industry.
CPR's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.95 | ||
| EV/EBITDA | 11.87 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)17.36
PEG (5Y)N/A
EPS Next 2Y4.61%
EPS Next 3Y7.09%
5. Dividend
5.1 Amount
CPR has a Yearly Dividend Yield of 1.10%. Purely for dividend investing, there may be better candidates out there.
CPR's Dividend Yield is slightly below the industry average, which is at 2.88.
Compared to an average S&P500 Dividend Yield of 1.96, CPR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.1% |
5.2 History
The dividend of CPR decreases each year by -2.80%.
Dividend Growth(5Y)-2.8%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CPR pays out 38.69% of its income as dividend. This is a sustainable payout ratio.
DP38.69%
EPS Next 2Y4.61%
EPS Next 3Y7.09%
BIT:CPR (12/12/2025, 7:00:00 PM)
5.982
+0.1 (+1.63%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)
Earnings (Next)
Inst Owners22.77%
Inst Owner ChangeN/A
Ins Owners51%
Ins Owner ChangeN/A
Market Cap7.37B
Revenue(TTM)3.07B
Net Income(TTM)201.60M
Analysts71.54
Price Target7.02 (17.35%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.1% |
Yearly Dividend0.04
Dividend Growth(5Y)-2.8%
DP38.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.93%
PT rev (3m)-0.33%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.21%
EPS NY rev (3m)2.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)-1.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.19 | ||
| Fwd PE | 18.41 | ||
| P/S | 2.4 | ||
| P/FCF | 22.95 | ||
| P/OCF | 11.29 | ||
| P/B | 1.99 | ||
| P/tB | 60.67 | ||
| EV/EBITDA | 11.87 |
EPS(TTM)0.17
EY2.84%
EPS(NY)0.32
Fwd EY5.43%
FCF(TTM)0.26
FCFY4.36%
OCF(TTM)0.53
OCFY8.85%
SpS2.49
BVpS3.01
TBVpS0.1
PEG (NY)17.36
PEG (5Y)N/A
Graham Number3.39
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.51% | ||
| ROE | 5.44% | ||
| ROCE | 9.58% | ||
| ROIC | 7.03% | ||
| ROICexc | 7.57% | ||
| ROICexgc | 17.42% | ||
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% | ||
| FCFM | 10.45% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
ROICexc(3y)8.52%
ROICexc(5y)8.34%
ROICexgc(3y)23.37%
ROICexgc(5y)25.9%
ROCE(3y)10.45%
ROCE(5y)9.91%
ROICexgc growth 3Y-20.45%
ROICexgc growth 5Y-21.73%
ROICexc growth 3Y-7.67%
ROICexc growth 5Y-5.91%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
F-Score6
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 8.49 | ||
| Debt/EBITDA | 2.97 | ||
| Cap/Depr | 230.39% | ||
| Cap/Sales | 10.79% | ||
| Interest Coverage | 6.41 | ||
| Cash Conversion | 81.69% | ||
| Profit Quality | 159.18% | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 2.58 |
F-Score6
WACC6.69%
ROIC/WACC1.05
Cap/Depr(3y)346.34%
Cap/Depr(5y)266.11%
Cap/Sales(3y)12.99%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-8.36%
EPS Next Y2.03%
EPS Next 2Y4.61%
EPS Next 3Y7.09%
EPS Next 5Y11.74%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%0.3%
Revenue Next Year1.47%
Revenue Next 2Y1.85%
Revenue Next 3Y2.98%
Revenue Next 5Y4.51%
EBIT growth 1Y6.42%
EBIT growth 3Y15.63%
EBIT growth 5Y10.27%
EBIT Next Year25.83%
EBIT Next 3Y12.31%
EBIT Next 5Y10.56%
FCF growth 1Y290.11%
FCF growth 3Y-14.61%
FCF growth 5Y-4.94%
OCF growth 1Y205.34%
OCF growth 3Y11.5%
OCF growth 5Y13.06%
DAVIDE CAMPARI-MILANO NV / CPR.MI FAQ
Can you provide the ChartMill fundamental rating for DAVIDE CAMPARI-MILANO NV?
ChartMill assigns a fundamental rating of 4 / 10 to CPR.MI.
What is the valuation status of DAVIDE CAMPARI-MILANO NV (CPR.MI) stock?
ChartMill assigns a valuation rating of 1 / 10 to DAVIDE CAMPARI-MILANO NV (CPR.MI). This can be considered as Overvalued.
What is the profitability of CPR stock?
DAVIDE CAMPARI-MILANO NV (CPR.MI) has a profitability rating of 4 / 10.
What is the valuation of DAVIDE CAMPARI-MILANO NV based on its PE and PB ratios?
The Price/Earnings (PE) ratio for DAVIDE CAMPARI-MILANO NV (CPR.MI) is 35.19 and the Price/Book (PB) ratio is 1.99.
How sustainable is the dividend of DAVIDE CAMPARI-MILANO NV (CPR.MI) stock?
The dividend rating of DAVIDE CAMPARI-MILANO NV (CPR.MI) is 2 / 10 and the dividend payout ratio is 38.69%.